{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:48:43Z","timestamp":1791298123514,"version":"4.1.0"},"reference-count":178,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.ejca.2012.10.004","type":"journal-article","created":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T20:36:11Z","timestamp":1351542971000},"page":"3355-3377","source":"Crossref","is-referenced-by-count":231,"title":["The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer"],"prefix":"10.1016","volume":"48","author":[{"given":"Fatima","family":"Cardoso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Loibl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Graziottin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Panizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Martincich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oreste","family":"Gentilini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedro","family":"Peccatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Fourquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzette","family":"Delaloge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Marotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Penault-Llorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Kotti-Kitromilidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Rodger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Harbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejca.2012.10.004_b0005","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.breast.2010.03.017","article-title":"Mammographic screening for breast cancer: an invited review of the benefits and costs","volume":"19","author":"Greif","year":"2010","journal-title":"Breast"},{"issue":"4","key":"10.1016\/j.ejca.2012.10.004_b0010","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.amjsurg.2009.06.010","article-title":"Diagnosis of breast cancer in women age 40 and younger: delays in diagnosis result from underuse of genetic testing and breast imaging","volume":"198","author":"Samphao","year":"2009","journal-title":"Am J Surg"},{"issue":"9","key":"10.1016\/j.ejca.2012.10.004_b0015","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1056\/NEJM198608283150906","article-title":"The relation between survival and age at diagnosis in breast cancer","volume":"315","author":"Adami","year":"1986","journal-title":"N Engl J Med"},{"issue":"7233","key":"10.1016\/j.ejca.2012.10.004_b0020","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/bmj.320.7233.474","article-title":"Factors influencing the effect of age on prognosis in breast cancer: population based study","volume":"320","author":"Kroman","year":"2000","journal-title":"BMJ"},{"issue":"17","key":"10.1016\/j.ejca.2012.10.004_b0025","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1200\/JCO.2006.10.3754","article-title":"Korean Breast Cancer Society poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea \u2013 a report from the Korean Breast Cancer Society","volume":"25","author":"Ahn","year":"2007","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2012.10.004_b0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.breast.2011.05.002","article-title":"Optimal adjuvant therapy for very young breast cancer patients","volume":"20","author":"Francis","year":"2011","journal-title":"Breast"},{"issue":"20","key":"10.1016\/j.ejca.2012.10.004_b0035","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1200\/JCO.2007.14.2471","article-title":"Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression","volume":"26","author":"Anders","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.004_b0040","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1200\/JCO.2010.28.9199","article-title":"Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes?","volume":"29","author":"Anders","year":"2011","journal-title":"J Clin Oncol"},{"issue":"8852","key":"10.1016\/j.ejca.2012.10.004_b0045","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0140-6736(93)92407-K","article-title":"Age as prognostic factor in premenopausal breast carcinoma","volume":"341","author":"de la Rochefordiere","year":"1993","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ejca.2012.10.004_b0050","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/CEJ.0b013e32832abd76","article-title":"Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study","volume":"18","author":"Cluze","year":"2009","journal-title":"Eur J Cancer Prev"},{"issue":"9","key":"10.1016\/j.ejca.2012.10.004_b0055","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/bjc.2011.120","article-title":"Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"104","author":"Metcalfe","year":"2011","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2012.10.004_b0060","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/02841860802056594","article-title":"Danish Breast Cancer Cooperative Group. Recurrence pattern and prognosis in low-risk breast cancer patients \u2013 data from the DBCG 89-A programme","volume":"47","author":"Christiansen","year":"2008","journal-title":"Acta Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2012.10.004_b0065","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ejca.2010.02.015","article-title":"Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group","volume":"46","author":"Sardanelli","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2012.10.004_b0070","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/sj.bjc.6600847","article-title":"Breast self-examination and death from breast cancer: a metaanalysis","volume":"88","author":"Hackshaw","year":"2003","journal-title":"Br J Cancer"},{"issue":"19","key":"10.1016\/j.ejca.2012.10.004_b0900","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/jnci\/94.19.1445","article-title":"Randomized trial of breast self-examination in Shanghai: final results","volume":"94","author":"Thomas","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2012.10.004_b0080","unstructured":"Breast Screening Programme. England 2007\u20132008. Published January 28, 2009. Office of National Statistics, London."},{"issue":"2","key":"10.1016\/j.ejca.2012.10.004_b0085","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1148\/radiol.2512081235","article-title":"Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data","volume":"251","author":"Vinnicombe","year":"2009","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.ejca.2012.10.004_b0905","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s00330-010-1968-3","article-title":"The impact of digital mammography on screening a young cohort of women for breast cancer in an urban specialist breast unit","volume":"21","author":"Perry","year":"2011","journal-title":"Eur Radiol"},{"issue":"8433","key":"10.1016\/j.ejca.2012.10.004_b0095","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(85)92204-4","article-title":"Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare","volume":"1","author":"Tab\u00e1r","year":"1985","journal-title":"Lancet"},{"issue":"9310","key":"10.1016\/j.ejca.2012.10.004_b0100","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0140-6736(02)08020-0","article-title":"Long-term effects of mammography screening: updated overview of the Swedish randomised trials","volume":"359","author":"Nystr\u00f6m","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejca.2012.10.004_b0105","first-page":"A4246","article-title":"Relation between breast cancer mortality and screening effectiveness: systematic review of the mammography trials","volume":"58","author":"G\u00f8tzsche","year":"2011","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.ejca.2012.10.004_b0110","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/jnci\/djq090","article-title":"Performance of first mammography examination in women younger than 40 years. For the breast cancer surveillance consortium","volume":"102","author":"Yankaskas","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"7 Suppl.","key":"10.1016\/j.ejca.2012.10.004_b0115","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/1097-0142(19920401)69:7+<1885::AID-CNCR2820691702>3.0.CO;2-B","article-title":"American Cancer Society guidelines on screening for breast cancer: an overview","volume":"69","author":"Dodd","year":"1992","journal-title":"Cancer"},{"issue":"7 Suppl. 1","key":"10.1016\/j.ejca.2012.10.004_b0120","doi-asserted-by":"crossref","first-page":"70S","DOI":"10.1097\/01.prs.0000286577.70026.5d","article-title":"Breast implants and breast cancer: a review of incidence, detection, mortality, and survival","volume":"120","author":"Deapen","year":"2007","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.ejca.2012.10.004_b0125","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/00006534-199012000-00014","article-title":"Mammographic measurements before and after augmentation mammaplasty","volume":"86","author":"Silverstein","year":"1990","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.ejca.2012.10.004_b0130","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/jama.291.4.442","article-title":"Effect of breast augmentation on the accuracy of mammography and cancer characteristics","volume":"291","author":"Miglioretti","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ejca.2012.10.004_b0135","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bjps.2007.06.035","article-title":"Augmentation mammoplasty: effect on diagnosis of breast cancer","volume":"61","author":"McIntosh","year":"2008","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"7 Suppl. 1","key":"10.1016\/j.ejca.2012.10.004_b0140","doi-asserted-by":"crossref","first-page":"81S","DOI":"10.1097\/01.prs.0000286578.94102.2b","article-title":"The effect of silicone implants on the diagnosis, prognosis, and treatment of breast cancer","volume":"120","author":"Handel","year":"2007","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.ejca.2012.10.004_b0145","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.breast.2004.02.012","article-title":"The diagnosis of breast cancer in women younger than 40","volume":"13","author":"Foxcroft","year":"2004","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.ejca.2012.10.004_b0150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1054\/brst.2001.0391","article-title":"The comparative sensitivity of mammography and ultrasound in women with breast symptoms: an age-specific analysis","volume":"11","author":"Houssami","year":"2002","journal-title":"Breast"},{"key":"10.1016\/j.ejca.2012.10.004_b0155","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1200\/JCO.2007.15.2108","article-title":"Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer","volume":"26","author":"Houssami","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2012.10.004_b0160","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10549-009-0616-6","article-title":"The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast","volume":"119","author":"Mann","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"33","key":"10.1016\/j.ejca.2012.10.004_b0165","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1200\/JCO.2008.21.5756","article-title":"Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management","volume":"27","author":"Brennan","year":"2009","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2012.10.004_b0170","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1200\/JCO.2009.23.0839","article-title":"Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial","volume":"28","author":"Kuhl","year":"2010","journal-title":"J Clin Oncol"},{"issue":"9714","key":"10.1016\/j.ejca.2012.10.004_b0175","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(09)62070-5","article-title":"Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial","volume":"375","author":"Turnbull","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ejca.2012.10.004_b0180","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ejca.2010.11.035","article-title":"Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET \u2013 randomised controlled trial","volume":"47","author":"Peters","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2012.10.004_b0185","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00330-004-2351-z","article-title":"The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer","volume":"14","author":"Fischer","year":"2004","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejca.2012.10.004_b0190","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1200\/JCO.2006.09.5448","article-title":"Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ","volume":"26","author":"Solin","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2012.10.004_b0195","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1245\/s10434-009-0607-1","article-title":"Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy","volume":"16","author":"Hwang","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2012.10.004_b0200","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/S0140-6736(11)61350-0","article-title":"MRI for breast cancer screening, diagnosis, and treatment","volume":"378","author":"Morrow","year":"2011","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ejca.2012.10.004_b0205","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3322\/caac.20028","article-title":"Review of pre-operative magnetic resonance imaging (MRI) in breast cancer: Should MRI be performed on all women with newly diagnosed, early stage breast cancer?","volume":"59","author":"Houssami","year":"2009","journal-title":"CA Cancer J Clin"},{"issue":"41","key":"10.1016\/j.ejca.2012.10.004_b0210","first-page":"162","article-title":"Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast","volume":"10","author":"Correa","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"8","key":"10.1016\/j.ejca.2012.10.004_b0215","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S1470-2045(06)70765-3","article-title":"Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network","volume":"7","author":"Omlin","year":"2006","journal-title":"Lancet Oncol"},{"issue":"19","key":"10.1016\/j.ejca.2012.10.004_b0220","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJMoa010874","article-title":"Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation","volume":"345","author":"Bartelink","year":"2001","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ejca.2012.10.004_b0225","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1023\/A:1011136326943","article-title":"Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial","volume":"12","author":"Veronesi","year":"2001","journal-title":"Ann Oncol"},{"issue":"16","key":"10.1016\/j.ejca.2012.10.004_b0230","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa020989","article-title":"Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer","volume":"347","author":"Veronesi","year":"2002","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.ejca.2012.10.004_b0235","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejca.2012.10.004_b0240","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.suronc.2008.03.004","article-title":"Nipple-sparing mastectomy: where are we now?","volume":"17","author":"Chung","year":"2008","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ejca.2012.10.004_b0910","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2011.29.15_suppl.1013","article-title":"Contralateral breast cancer risk in patients with familial breast cancer who tested negative for BRCA1 and BRCA2","volume":"29","author":"Rhiem","year":"2011","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.ejca.2012.10.004_b0250","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1200\/JCO.2005.02.7888","article-title":"Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1\/2-associated stage I\/II breast cancer","volume":"24","author":"Pierce","year":"2006","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2012.10.004_b0255","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1245\/s10434-009-0638-7","article-title":"Breast-conserving surgery in BRCA1\/2 mutation carriers: are we approaching an answer?","volume":"16","author":"Garcia-Etienne","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"19","key":"10.1016\/j.ejca.2012.10.004_b0260","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2000.18.19.3360","article-title":"Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1\/2 mutations","volume":"18","author":"Pierce","year":"2000","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2012.10.004_b0265","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","volume":"8","author":"Krag","year":"2007","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2012.10.004_b0270","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/annonc\/mdh355","article-title":"Safety of sentinel node biopsy in pregnant patients with breast cancer","volume":"15","author":"Gentilini","year":"2004","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.004_b0275","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00259-009-1217-7","article-title":"Sentinel lymph node biopsy in pregnant patients with breast cancer","volume":"37","author":"Gentilini","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.ejca.2012.10.004_b0280","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archsurg.2009.269","article-title":"Underuse of axillary dissection for the management of sentinel node micrometastases in breast cancer","volume":"145","author":"Wasif","year":"2010","journal-title":"Arch Surg"},{"issue":"6","key":"10.1016\/j.ejca.2012.10.004_b0285","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.004_b0290","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clon.2007.10.004","article-title":"Elucidating the role of chest wall irradiation in \u2018intermediate-risk\u2019 breast cancer: the MRC\/EORTC SUPREMO trial","volume":"20","author":"Kunkler","year":"2008","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"9217","key":"10.1016\/j.ejca.2012.10.004_b0295","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(00)02263-7","article-title":"Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials","volume":"355","year":"2000","journal-title":"Lancet"},{"issue":"9503","key":"10.1016\/j.ejca.2012.10.004_b0300","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2012.10.004_b0305","first-page":"1095","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial","volume":"371","author":"Bentzen","year":"2008","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.ejca.2012.10.004_b0310","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1200\/JCO.2007.11.4991","article-title":"Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial","volume":"25","author":"Bartelink","year":"2007","journal-title":"J Clin Oncol"},{"issue":"9735","key":"10.1016\/j.ejca.2012.10.004_b0315","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(10)60837-9","article-title":"Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial","volume":"376","author":"Vaidya","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.004_b0320","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.semradonc.2010.09.001","article-title":"The impact of age on outcome in early-stage breast cancer","volume":"21","author":"Beadle","year":"2011","journal-title":"Semin Radiat Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2012.10.004_b0325","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1245\/s10434-008-9832-2","article-title":"Screening for recurrences in patients treated with breast-conserving surgery: is there a role for MRI?","volume":"15","author":"Gorechlad","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2012.10.004_b0940","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ejso.2011.07.005","article-title":"Factors influencing loco-regional relapse in older breast cancer patients treated with tumour resection and tamoxifen","volume":"37","author":"Kontos","year":"2011","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2012.10.004_b0335","first-page":"790","article-title":"Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer","volume":"305","author":"Houssami","year":"2011","journal-title":"Eur J Surg Oncol JAMA"},{"issue":"10","key":"10.1016\/j.ejca.2012.10.004_b0340","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1245\/s10434-010-1087-z","article-title":"Impact of US surveillance on detection of clinically occult locoregional recurrence after mastectomy for breast cancer","volume":"17","author":"Kim","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2012.10.004_b0345","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1148\/radiol.2523081977","article-title":"US surveillance of regional lymph node recurrence after breast cancer surgery","volume":"252","author":"Moon","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.ejca.2012.10.004_b0350","first-page":"35","article-title":"Breast cancer outcome and predictors of outcome: are there age differentials?","volume":"16","author":"Albain","year":"1994","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"10","key":"10.1016\/j.ejca.2012.10.004_b0355","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/annonc\/mdq072","article-title":"Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35years) with operable breast cancer","volume":"21","author":"Cancello","year":"2010","journal-title":"Ann Oncol"},{"issue":"27","key":"10.1016\/j.ejca.2012.10.004_b0360","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","article-title":"multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer","volume":"351","author":"Paik","year":"2004","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.ejca.2012.10.004_b0945","article-title":"Quantitative Gene Expression analysis in a large cohort of estrogen-receptor positive breast cancers: characterization of the tumor profiles in younger patients (\u2a7d40yrs) and in older patients (\u2a7e70yrs)","volume":"70","author":"Shak","year":"2010","journal-title":"Cancer Res"},{"issue":"17","key":"10.1016\/j.ejca.2012.10.004_b0370","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/jnci\/djj329","article-title":"Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer","volume":"98","author":"Buyse","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.ejca.2012.10.004_b0375","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1200\/JCO.2006.07.1522","article-title":"Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade","volume":"25","author":"Loi","year":"2007","journal-title":"J Clin Oncol"},{"issue":"9606","key":"10.1016\/j.ejca.2012.10.004_b0915","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(08)60069-0","article-title":"Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials","volume":"371","author":"Clarke","year":"2008","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.ejca.2012.10.004_b0385","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMoa0909638","article-title":"Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer","volume":"362","author":"Swain","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.004_b0390","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10549-010-1103-9","article-title":"Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study","volume":"124","author":"Huober","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.ejca.2012.10.004_b0395","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10549-007-9509-8","article-title":"Risk of second non-hematological malignancies among 376,825 breast cancer survivors","volume":"106","author":"Brown","year":"2007","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.004_b0400","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrclinonc.2010.133","article-title":"A changing perspective: improving access to fertility preservation","volume":"8","author":"Letourneau","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2012.10.004_b0405","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jnci\/dji021","article-title":"Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis","volume":"97","author":"Mauri","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.ejca.2012.10.004_b0410","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1200\/JCO.1998.16.8.2672","article-title":"Effect of preoperative chemotherapy on the outcome of women with operable breast cancer","volume":"16","author":"Fisher","year":"1998","journal-title":"J Clin Oncol"},{"issue":"9169","key":"10.1016\/j.ejca.2012.10.004_b0415","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(99)05036-9","article-title":"Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial","volume":"353","author":"Fisher","year":"1999","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.004_b0420","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3816\/CBC.2002.n.013","article-title":"Young age as an independent adverse prognostic factor in premenopausal patients with breast cancer","volume":"3","author":"Dubsky","year":"2002","journal-title":"Clin Breast Cancer"},{"issue":"24","key":"10.1016\/j.ejca.2012.10.004_b0425","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/jnci\/djq409","article-title":"Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials","volume":"102","author":"Bonilla","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2012.10.004_b0430","unstructured":"Available from: www.ago-online.org."},{"issue":"8","key":"10.1016\/j.ejca.2012.10.004_b0435","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1200\/JCO.2003.09.081","volume":"21","author":"Citron","year":"2003","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2012.10.004_b0440","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jnci\/djm287","article-title":"Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial","volume":"100","author":"Francis","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.004_b0445","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejca.2010.10.013","article-title":"2010 Update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours","volume":"47","author":"Aapro","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2012.10.004_b0450","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1200\/JCO.2010.32.5704","article-title":"Effect of luteinizing hormone\u2013releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study","volume":"29","author":"Gerber","year":"2011","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2012.10.004_b0455","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/jama.2011.991","article-title":"Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial","volume":"306","author":"Del Mastro","year":"2011","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.ejca.2012.10.004_b0460","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1200\/JCO.2010.32.5704","article-title":"Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study","volume":"29","author":"Gerber","year":"2011","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2012.10.004_b0465","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/annonc\/mdn005","article-title":"Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial","volume":"19","author":"Untch","year":"2008","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2012.10.004_b0470","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1470-2045(11)70122-X","article-title":"Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial","volume":"12","author":"Gnant","year":"2011","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2012.10.004_b0475","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ejca.2006.11.019","article-title":"Phosphorylated HER-2 tyrosine kinase and Her-2\/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC)","volume":"43","author":"Giuliani","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2012.10.004_b0480","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/jnci\/djp235","article-title":"On behalf of the ESO\u2013MBC task force. International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy","volume":"101","author":"Cardoso","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2012.10.004_b0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djq029","article-title":"International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)\u2013MBC task force: can metastatic breast cancer be cured?","volume":"102","author":"Pagani","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl. 6","key":"10.1016\/j.ejca.2012.10.004_b0950","doi-asserted-by":"crossref","first-page":"vi 25","DOI":"10.1093\/annonc\/mdr372","article-title":"On behalf of the ESMO Guidelines Working Group. Locally recurrent or metastatic breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up","author":"Cardoso","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2012.10.004_b0495","unstructured":"Available from: www.nccn.org."},{"key":"10.1016\/j.ejca.2012.10.004_b0500","unstructured":"Available from: www.canceraustralia.nbocc.org.au."},{"key":"10.1016\/j.ejca.2012.10.004_b0505","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1200\/JCO.2000.18.22.3768","article-title":"Quality-of-life scores predict outcome in metastatic but not early breast cancer","volume":"18","author":"Coates","year":"2000","journal-title":"J Clin Oncol"},{"issue":"3 Suppl.","key":"10.1016\/j.ejca.2012.10.004_b0510","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/cncr.23189","article-title":"Combining endocrine agents with chemotherapy: which patients and what sequence?","volume":"112","author":"Pritchard","year":"2008","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2012.10.004_b0515","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1634\/theoncologist.6-6-538","article-title":"Combination endocrine therapy in the management of breast cancer","volume":"6","author":"Michaud","year":"2001","journal-title":"Oncologist"},{"issue":"25","key":"10.1016\/j.ejca.2012.10.004_b0520","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1200\/JCO.2009.24.9565","article-title":"Phase II trial of anastrozole plus goserelin in the treatment of hormone receptor-positive, metastatic carcinoma of the breast in premenopausal women","volume":"28","author":"Carlson","year":"2010","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.ejca.2012.10.004_b0525","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1200\/JCO.2009.26.5884","article-title":"Phase II parallel group study showing comparable efficacy between premenopausal metastatic breast cancer patients treated with letrozole plus goserelin and postmenopausal patients treated with letrozole alone as first-line hormone therapy","volume":"28","author":"Park","year":"2010","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2012.10.004_b0530","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/sj.bjc.6601557","article-title":"Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer","volume":"90","author":"Forward","year":"2004","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.004_b0535","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejca.2006.08.019","article-title":"Effects of fulvestrant 250mg in premenopausal women with oestrogen receptor-positive primary breast cancer","volume":"43","author":"Robertson","year":"2007","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2012.10.004_b0540","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ejca.2007.11.007","article-title":"Effects of fulvestrant 750mg in premenopausal women with oestrogen-receptor-positive primary breast cancer","volume":"44","author":"Young","year":"2008","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2012.10.004_b0545","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/cncr.22041","article-title":"Primary breast cancer phenotypes associated with propensity for central nervous system metastases","volume":"107","author":"Tham","year":"2006","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2012.10.004_b0550","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0959-8049(98)00421-3","article-title":"Brain metastases in breast cancer: prognostic factors and management","volume":"35","author":"Lentzsch","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2012.10.004_b0555","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10549-004-0999-3","article-title":"Central nervous system metastases in women after multimodality therapy for high risk breast cancer","volume":"88","author":"Carey","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejca.2012.10.004_b0560","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.clon.2004.03.012","article-title":"Brain metastases from breast cancer: identification of a high-risk group","volume":"16","author":"Evans","year":"2004","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.004_b0565","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/j.seminoncol.2007.11.018","article-title":"The epidemiology of inflammatory breast cancer","volume":"35","author":"Levine","year":"2008","journal-title":"Semin Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2012.10.004_b0570","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3322\/caac.20082","article-title":"Inflammatory breast cancer: the disease, the biology, the treatment","volume":"60","author":"Robertson","year":"2010","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.004_b0575","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1040-8428(02)00134-8","article-title":"Effects of age on coping and psychological distress in women diagnosed with breast cancer: review of literature and analysis of two different geographical settings","volume":"46","author":"Baider","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"issue":"10","key":"10.1016\/j.ejca.2012.10.004_b0580","first-page":"1555","article-title":"Quality of life, survivorship, and psychosocial adjustment of young women with breast cancer after breast-conserving surgery and radiation therapy","volume":"27","author":"Dow","year":"2000","journal-title":"Oncol Nurs Forum"},{"issue":"8","key":"10.1016\/j.ejca.2012.10.004_b0585","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/pon.1792","article-title":"The experiences, needs and concerns of younger women with breast cancer: a meta-ethnography","volume":"20","author":"Adams","year":"2011","journal-title":"Psychooncology"},{"issue":"5","key":"10.1016\/j.ejca.2012.10.004_b0590","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1200\/JCO.2007.14.2851","article-title":"Implementing a survivorship care plan for patients with breast cancer","volume":"26","author":"Ganz","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2012.10.004_b0595","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/archinternmed.2010.503","article-title":"Cigarette smoking and the incidence of breast cancer","volume":"171","author":"Xue","year":"2011","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.ejca.2012.10.004_b0600","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/NCC.0b013e3181c024bb","article-title":"Parents\u2019 experience of cancer who have young children: a literature review","volume":"33","author":"Semple","year":"2010","journal-title":"Cancer Nurs"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.004_b0605","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/pon.1387","article-title":"Breast cancer in young families: a qualitative interview study of fathers and their role and communication with their children following the diagnosis of maternal breast cancer","volume":"18","author":"Forrest","year":"2009","journal-title":"Psychooncology"},{"issue":"7548","key":"10.1016\/j.ejca.2012.10.004_b0610","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1136\/bmj.38793.567801.AE","article-title":"Breast cancer in the family\u2013children\u2019s perceptions of their mother\u2019s cancer and its initial treatment: qualitative study","volume":"332","author":"Forrest","year":"2006","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.ejca.2012.10.004_b0615","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.ejca.2007.04.006","article-title":"Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI","volume":"43","author":"Partridge","year":"2007","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2012.10.004_b0620","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humupd\/dmn064","article-title":"Breast cancer in young women and its impact on reproductive function","volume":"15","author":"Hickey","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejca.2012.10.004_b0625","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3233\/BD-2004-21108","article-title":"Long-term complications of adjuvant chemotherapy for early stage breast cancer","volume":"21","author":"Partridge","year":"2004","journal-title":"Breast Dis"},{"key":"10.1016\/j.ejca.2012.10.004_b0630","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1470-2045(05)70254-0","article-title":"What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?","volume":"6","author":"Thewes","year":"2005","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2012.10.004_b0635","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10549-009-0401-6","article-title":"The fertility-related concerns, needs and preferences of younger women with breast cancer: a systematic review","volume":"116","author":"Peate","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.ejca.2012.10.004_b0640","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.fertnstert.2010.03.043","article-title":"Self-assessed knowledge of treatment and fertility preservation in young women with breast cancer","volume":"94","author":"Jukkala","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejca.2012.10.004_b0920","series-title":"Menopause: the state of the art","first-page":"408","article-title":"Sexuality, ageing and chronic diseases: iatrogenic premature menopause in cancer survivors","author":"Graziottin","year":"2003"},{"key":"10.1016\/j.ejca.2012.10.004_b0925","first-page":"254","article-title":"Menopause and sexuality: key issues in premature menopause and beyond","volume":"vol. 1205","author":"Graziottin","year":"2010"},{"issue":"428","key":"10.1016\/j.ejca.2012.10.004_b0655","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1001\/jama.289.21.2827","article-title":"Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial","author":"Stearns","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2012.10.004_b0660","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/annonc\/mdl478","article-title":"Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients\u2013a double-blind, randomized study","volume":"18","author":"Loibl","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2012.10.004_b0665","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/01.gme.0000227397.76063.e4","article-title":"Newer antidepressants inhibit hot flashes","volume":"13","author":"Loprinzi","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.ejca.2012.10.004_b0670","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4088\/JCP.v68n0619","article-title":"Treatment of depression and menopause-related symptoms with the serotonin-norepenephrine reuptake inhibitor duloxetine","volume":"68","author":"Joffe","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.ejca.2012.10.004_b0675","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1200\/JCO.2009.23.5150","article-title":"Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial","volume":"28","author":"Walker","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2012.10.004_b0680","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.maturitas.2010.11.013","article-title":"Management of menopausal symptoms in breast cancer patients","volume":"68","author":"Loibl","year":"2011","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.ejca.2012.10.004_b0685","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.fertnstert.2009.03.045","article-title":"Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer","volume":"94","author":"Partridge","year":"2010","journal-title":"Fertil Steril"},{"issue":"9744","key":"10.1016\/j.ejca.2012.10.004_b0690","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(10)60355-8","article-title":"Primary ovarian insufficiency","volume":"376","author":"De Vos","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejca.2012.10.004_b0695","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1054\/brst.2000.0133","article-title":"Pregnancy in a breast cancer patient treated with a LHRH analogue at ablative doses","volume":"9","author":"Jim\u00e9nez-Gordo","year":"2000","journal-title":"Breast"},{"issue":"3","key":"10.1016\/j.ejca.2012.10.004_b0700","first-page":"521","article-title":"Contraceptive methods after gynecological and breast cancer","volume":"194","author":"Blanc","year":"2010","journal-title":"Bull Acad Natl Med"},{"issue":"6","key":"10.1016\/j.ejca.2012.10.004_b0705","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/07357900701506672","article-title":"Renaming \u201cchemobrain\u201d","volume":"25","author":"Huria","year":"2007","journal-title":"Cancer Invest"},{"issue":"12","key":"10.1016\/j.ejca.2012.10.004_b0710","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/cncr.24287","article-title":"The effect of Modafinil on cognitive function in Breast cancer survivors","volume":"115","author":"Kohli","year":"2009","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.004_b0715","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/000331979704800115","article-title":"Efficacy of Daflon 500mg in the treatment of lymphedema (secondary to conventional therapy of breast cancer)","volume":"48","author":"Pecking","year":"1997","journal-title":"Angiology"},{"issue":"3 Suppl. 1","key":"10.1016\/j.ejca.2012.10.004_b0720","first-page":"39","article-title":"Evaluation by lymphoscintigraphy of the effect of a micronized flavonoid fraction (Daflon 500mg) in the treatment of upper limb lymphedema","volume":"14","author":"Pecking","year":"1995","journal-title":"Int Angiol"},{"issue":"32","key":"10.1016\/j.ejca.2012.10.004_b0725","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1200\/JCO.2008.16.3725","article-title":"Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements","volume":"26","author":"McLaughlin","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2012.10.004_b0930","series-title":"The management of the menopause. The millennium review 2000","first-page":"211","article-title":"Sexuality and breast cancer: a review","author":"Graziottin","year":"2000"},{"issue":"6","key":"10.1016\/j.ejca.2012.10.004_b0735","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/01.GME.0000139926.02689.A1","article-title":"Sexual dysfunctions in women with premature menopause","volume":"11","author":"Graziottin","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.ejca.2012.10.004_b0740","first-page":"177","article-title":"Sexuality and body image in younger women with breast cancer","volume":"16","author":"Schover","year":"1994","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.ejca.2012.10.004_b0935","series-title":"Women\u2019s sexual function and dysfunction: study, diagnosis and treatment","first-page":"276","article-title":"Breast cancer and its effects on women\u2019s self-image and sexual function","author":"Graziottin","year":"2006"},{"issue":"2","key":"10.1016\/j.ejca.2012.10.004_b0750","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF01806673","article-title":"Breast cancer survivors: psychosocial concerns and quality of life","volume":"38","author":"Ganz","year":"1996","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejca.2012.10.004_b0755","series-title":"Evidence-based physical therapy for the pelvic floor \u2013 bridging science and clinical practice","first-page":"277","article-title":"Female sexual dysfunction: treatment","author":"Graziottin","year":"2007"},{"issue":"9","key":"10.1016\/j.ejca.2012.10.004_b0760","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3109\/09513591003767948","article-title":"Urogenital disorders associated with estrogen deficiency: the role of promestriene as topical estrogen therapy","volume":"26","author":"Santos","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejca.2012.10.004_b0765","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/713605341","article-title":"A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer","volume":"6","author":"Dew","year":"2003","journal-title":"Climacteric"},{"key":"10.1016\/j.ejca.2012.10.004_b0770","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1634\/theoncologist.2007-0234","article-title":"Should urogenital atrophy in breast cancer survivors be treated with topical estrogens","volume":"13","author":"Trinkaus","year":"2008","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.ejca.2012.10.004_b0775","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.maturitas.2010.03.027","article-title":"Sexuality after breast cancer: a review","volume":"66","author":"Emilee","year":"2010","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.ejca.2012.10.004_b0780","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejon.2010.07.008","article-title":"Sexuality and quality of life of breast cancer patients post mastectomy","volume":"15","author":"Manganiello","year":"2011","journal-title":"Eur J Oncol Nurs"},{"key":"10.1016\/j.ejca.2012.10.004_b0790","first-page":"183","article-title":"Breast cancer in younger women: effects on interpersonal and family relations","volume":"16","author":"Northouse","year":"1994","journal-title":"Monogr Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.004_b0795","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10549-009-0398-x","article-title":"Addressing intimacy and partner communication after breast cancer: a randomized controlled group intervention","volume":"118","author":"Rowland","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"31","key":"10.1016\/j.ejca.2012.10.004_b0800","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1200\/JCO.2010.30.5748","article-title":"Value of early referral to fertility preservation in young women with breast cancer","volume":"28","author":"Lee","year":"2010","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1016\/j.ejca.2012.10.004_b0805","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1200\/JCO.2006.06.5888","article-title":"American Society of Clinical Oncology recommendations on fertility preservation in cancer patients","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"issue":"Suppl. 4","key":"10.1016\/j.ejca.2012.10.004_b0810","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/annonc\/mdp166","article-title":"Cancer, fertility and pregnancy: ESMO clinical recommendations for diagnosis, treatment and follow-up","volume":"20","author":"Pentheroudakis","year":"2009","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2012.10.004_b0815","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jamcollsurg.2009.08.006","article-title":"Timing of breast cancer treatments with oocyte retrieval and embryo cryopreservation","volume":"209","author":"Baynosa","year":"2009","journal-title":"J Am Coll Surg"},{"issue":"3","key":"10.1016\/j.ejca.2012.10.004_b0820","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10549-010-0996-7","article-title":"Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis","volume":"122","author":"Ben-Aharon","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejca.2012.10.004_b0825","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/humrep\/deg045","article-title":"Fertility preservation in breast cancer patients: in vitro fertilization and embryo cryopreservation after ovarian stimulation with tamoxifen","volume":"18","author":"Oktay","year":"2003","journal-title":"Human Reprod"},{"key":"10.1016\/j.ejca.2012.10.004_b0830","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(04)15728-0","article-title":"Embryo development after heterotopic transplantation of cryopreserved ovarian tissue","volume":"363","author":"Oktay","year":"2004","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ejca.2012.10.004_b0835","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1056\/NEJMra0801454","article-title":"Preservation of fertility in patients with cancer","volume":"360","author":"Jeruss","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejca.2012.10.004_b0840","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/GRF.0b013e3181f96e00","article-title":"Fertility preservation in women with breast cancer","volume":"53","author":"Rodriguez-Wallberg","year":"2010","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.004_b0845","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/cncr.25398","article-title":"Incorporating fertility preservation into the care of young oncology patients","volume":"117","author":"Redig","year":"2011","journal-title":"Cancer"},{"issue":"16","key":"10.1016\/j.ejca.2012.10.004_b0850","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1200\/JCO.2007.14.8700","article-title":"Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study","volume":"26","author":"Azim","year":"2008","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2012.10.004_b0855","first-page":"401","article-title":"Cryopreservation of ovarian tissue: an overview","volume":"100","author":"Donnez","year":"2009","journal-title":"Minerva Med"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.004_b0860","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bpobgyn.2009.09.002","article-title":"Orthotopic and heterotopic ovarian tissue transplantation","volume":"24","author":"Sonmezer","year":"2010","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.004_b0865","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.fertnstert.2009.02.055","article-title":"Fertility preservation in women with breast cancer undergoing adjuvant chemotherapy: a systematic review","volume":"94","author":"Cruz","year":"2010","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.ejca.2012.10.004_b0870","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.fertnstert.2009.03.109","article-title":"Culture of cryopreserved ovarian tissue: state of the art in 2008","volume":"91","author":"Fabbri","year":"2009","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.004_b0875","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejca.2010.09.007","article-title":"Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies","volume":"47","author":"Azim","year":"2011","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2012.10.004_b0880","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10549-011-1643-7","article-title":"Pregnancy after breast cancer: if you wish, ma\u2019am","volume":"129","author":"Pagani","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.ejca.2012.10.004_b0885","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10549-008-9983-7","article-title":"Breast-feeding after breast cancer: if you wish, madam","volume":"114","author":"Azim","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.ejca.2012.10.004_b0890","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.breast.2010.05.018","article-title":"Breastfeeding in breast cancer survivors: pattern, behaviour and effect on breast cancer outcome","volume":"19","author":"Azim","year":"2010","journal-title":"Breast"},{"issue":"18","key":"10.1016\/j.ejca.2012.10.004_b0895","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.ejca.2010.09.010","article-title":"Breast cancer in pregnancy: recommendations of an international consensus meeting","volume":"46","author":"Amant","year":"2010","journal-title":"Eur J Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804912007927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804912007927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T07:06:50Z","timestamp":1594796810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804912007927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":178,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0959804912007927"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2012.10.004","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}